StoxTruAlt Bioenergy Limited
NSE: TRUALT · Unclassified
Ask the data
Instant answers about TruAlt Bioenergy Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 1,728 |
| EBITDA | 290 |
| Operating margin | 16.8% |
| Interest | 160 |
| Depreciation | 86 |
| Profit before tax | 130 |
| Tax | 33 |
| Net profit | 96 |
| EPS ₹ | 12.30 |
| Operating cash flow | -289 |
| Capex | 511 |
| Dividend paid | 0 |
| Total assets | 3,778 |
| Equity | 1,520 |
Quarterly performance
last 6 quarters · ₹ crore| JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|
| Revenue | 304 | 115 | 713 | 596 | 627 | 811 |
| Operating profit | 42 | -5 | 134 | 119 | 133 | 101 |
| Operating margin | 13.7% | -4.0% | 18.8% | 19.9% | 21.2% | 12.5% |
| Other income | 23 | 15 | 18 | 31 | 15 | 13 |
| Interest | 38 | 39 | 40 | 44 | 44 | 42 |
| Depreciation | 21 | 21 | 22 | 23 | 25 | 24 |
| Profit before tax | 6 | -49 | 90 | 84 | 78 | 47 |
| Tax | 1 | -11 | 20 | 23 | 19 | 12 |
| Net profit | 5 | -38 | 69 | 60 | 57 | 35 |
| EPS ₹ | 0.67 | -5.37 | 8.07 | 6.99 | 6.67 | 4.04 |
| Revenue YoY | — | — | — | — | 106.3% | 606.2% |
| Profit YoY | — | — | — | — | 1108.2% | — |
Returns & margins
trailing-twelve-month, per quarter| MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|
| ROE | 6.3% | 9.8% | 13.7% |
| ROCE | 9.2% | 11.7% | 14.3% |
| Net margin | 5.6% | 7.2% | 8.0% |
| EBITDA margin | 16.8% | 18.6% | 17.7% |
| Debt / equity | 1.08 | 1.08 | 1.02 |
| Interest coverage | 1.81 | 2.22 | 2.76 |
| Asset turnover | 0.46 | 0.54 | 0.76 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|
| Share capital | 86 | 86 | 86 |
| Other equity / reserves | 1,316 | 1,435 | 1,533 |
| Total equity | 1,402 | 1,520 | 1,619 |
| Borrowings | 1,539 | 1,646 | 1,653 |
| Current liabilities | 816 | 1,085 | 850 |
| Non-current liabilities | 1,160 | 1,115 | 1,083 |
| Total assets | 3,377 | 3,778 | 3,620 |
| Property, plant & equipment | 1,648 | 2,052 | 1,874 |
| Capital work-in-progress | 242 | 68 | 189 |
| Investments | 5 | 4 | 34 |
| Inventories | 47 | 528 | 206 |
| Receivables | 63 | 406 | 367 |
| Cash & equivalents | 290 | 88 | 27 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | -289 |
| Cash from investing | -420 |
| Cash from financing | 648 |
| Capex | 511 |
| Free cash flow | -800 |
| Dividends paid | 0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| TruAlt Bioenergy Limited | 3,029 | 353.25 | 13.7 | 1.87 | 13.7% |
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of TruAlt Bioenergy Limited?
TruAlt Bioenergy Limited (TRUALT) closed at ₹353.25 on NSE on 06 Nov 2026.
What is the market cap of TruAlt Bioenergy Limited?
₹3,029 crore at the latest close.
What is the P/E ratio of TruAlt Bioenergy Limited?
13.7, on trailing-twelve-month earnings from its filings.
How fast is TruAlt Bioenergy Limited growing?
TruAlt Bioenergy Limited: Latest-quarter revenue is up 606.2% year on year.
How profitable is TruAlt Bioenergy Limited?
On a trailing-twelve-month basis return on equity is 13.7%, return on capital employed 14.3%, operating margin 17.7%, net margin 8.0%.
How much debt does TruAlt Bioenergy Limited have?
TruAlt Bioenergy Limited is moderately geared: debt to equity is 1.02 with borrowings of ₹1,653 cr against cash of ₹27 cr (balance sheet of 2026-09-30). Operating profit covers interest 2.8 times.
Financials parsed from TruAlt Bioenergy Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '25, annual from FY26, balance sheet from Sep '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.